Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rugang Zhang

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Frontiers in Oncology|March 16, 2013
Role of EZH2 in Epithelial Ovarian Cancer: From Biological Insights to Therapeutic TargetHua Li, Rugang Zhang
Nature Metabolism|November 17, 2020
CD38-expressing macrophages drive age-related NAD<sup>+</sup> declineShuai Wu, Rugang Zhang
Molecular & Cellular Oncology|June 19, 2019
NAD<sup>+</sup> metabolism controls inflammation during senescenceTimothy Nacarelli, Rugang Zhang
Molecular & Cellular Oncology|September 18, 2020
Targeting CARM1 in ovarian cancer with EZH2 and PARP inhibitorsSergey Karakashev, Rugang Zhang
Cell Cycle (Georgetown, Tex.)|March 23, 2007
Heterochromatin and its relationship to cell senescence and cancer therapyRugang Zhang, Peter D Adams
Molecular & Cellular Oncology|June 17, 2016
Metabolic alterations accompanying oncogene-induced senescenceKatherine M Aird, Rugang Zhang
Cancer Letters|February 4, 2014
Nucleotide metabolism, oncogene-induced senescence and cancerKatherine M Aird, Rugang Zhang
Oncotarget|July 6, 2015
ATM in senescenceKatherine M Aird, Rugang Zhang
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Detection of senescence-associated heterochromatin foci (SAHF)Katherine M Aird, Rugang Zhang
Molecular Oncology|June 8, 2022
Targeting cellular senescence to combat cancer and ageingChen Wang, Xue Hao, Rugang Zhang
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Frontiers in Oncology|March 16, 2013
Role of EZH2 in Epithelial Ovarian Cancer: From Biological Insights to Therapeutic TargetHua Li, Rugang Zhang
Nature Metabolism|November 17, 2020
CD38-expressing macrophages drive age-related NAD<sup>+</sup> declineShuai Wu, Rugang Zhang
Molecular & Cellular Oncology|June 19, 2019
NAD<sup>+</sup> metabolism controls inflammation during senescenceTimothy Nacarelli, Rugang Zhang
Molecular & Cellular Oncology|September 18, 2020
Targeting CARM1 in ovarian cancer with EZH2 and PARP inhibitorsSergey Karakashev, Rugang Zhang
Cell Cycle (Georgetown, Tex.)|March 23, 2007
Heterochromatin and its relationship to cell senescence and cancer therapyRugang Zhang, Peter D Adams
Molecular & Cellular Oncology|June 17, 2016
Metabolic alterations accompanying oncogene-induced senescenceKatherine M Aird, Rugang Zhang
Cancer Letters|February 4, 2014
Nucleotide metabolism, oncogene-induced senescence and cancerKatherine M Aird, Rugang Zhang
Oncotarget|July 6, 2015
ATM in senescenceKatherine M Aird, Rugang Zhang
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Detection of senescence-associated heterochromatin foci (SAHF)Katherine M Aird, Rugang Zhang
Molecular Oncology|June 8, 2022
Targeting cellular senescence to combat cancer and ageingChen Wang, Xue Hao, Rugang Zhang
Pageof 15